Navigation Links
Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment
Date:5/20/2008

Relief soon to be widely available for chronic pain sufferers.

MARKHAM, ON, May 20 /PRNewswire-FirstCall/ - Innolife Pharma, Inc. (Other OTC:INNP.PK - News) is pleased to announce that it has acquired North American licensing rights to the Natural Pain Relief Center non-narcotic proprietary breakthrough in the treatment of chronic pain.

Today, one in five Americans suffer with chronic pain (~ 60 million adults) spending approximately $120 Billion a year and the aging baby boomers have reported in surveys more aches and pains than any previous generation.

New Medical Finding with Brain Scans and Functional MRI's

Modern Brain Imaging has revealed that most chronic pain is the result of the brain's inability to turn off pain messages from the body. In chronic pain the brain simply is not producing and releasing enough natural pain killers (such as endorphins) to stop the person's suffering. These new medical findings show that chronic pain sufferers from headaches, migraines, fibromyalgia, back pain, sciatica, arthritis or a combination of all of them, are caused by a low level of Natural Pain Killer's (such as Endorphins and others) in the brain, as compared to people without chronic pain.

Over three years of in-clinic testing showed that this breakthrough all-natural program relieved significant chronic pain in 8 out of 10 people and with sustainable results. This non-narcotic, combination treatment has been receiving accolades from chronic pain sufferers with major improvement in mood and energy and dramatic decreases in pain levels, allowing a return to normal life function.

Innolife Pharma Inc. has an aggressive growth plan in place with a projected target of 95 licensed clinics in 3 years with projected top line annual revenue in excess of $30 million and a projected bottom line profit of over $12 million annually (40+%).

With the aging demographic, chronic pain is becoming a larger and larger internation
'/>"/>

SOURCE Innolife Pharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Innolife Pharma Provides Initial Update on Negotiations for Significant Product Joint Venture
2. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
3. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
9. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
10. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , , MONDAY, May 20 (HealthDay News) -- Young drivers ... higher risk of getting into car crashes, but Australian ... sleep on weekends puts them in even greater danger ... another challenge to adolescents that comes with lack of ... of the Center for Injury Research and Prevention at ...
(Date:5/21/2013)... , , MONDAY, May 20 (HealthDay News) -- Long-acting ... chronic obstructive pulmonary disease (COPD) may raise the ... new large Canadian study reveals. The finding ... prescribed long-acting bronchodilators -- either anticholinergics (such as ... are commonly used to relieve the shortness of ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Thousands of ... from the lung condition known as chronic obstructive ... that patients placed on the common antibiotic azithromycin ... due to flare-ups of the disease. "Given ... of such events is critical," said Victoria Richards, ...
(Date:5/21/2013)... (HealthDay News) -- Racial disparities exist in the treatment ... United States, according to a large new study. ... part of their initial treatment, researchers found that blacks ... surgery in the early stages of the disease. Hispanics ... and stage 2 disease than white patients. "In ...
(Date:5/21/2013)... The surgical management of non-small cell lung cancer ... race of the patient, according to a new study., ... and Stage II NSCLC is surgery," said researcher Jayanth ... Omaha, Nebraska. "In our study of more than 1,200,000 ... years 2000 and 2010, we found statistically significant racial ...
Breaking Medicine News(10 mins):Health News:Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 2Health News:Certain COPD Meds Might Raise Heart Risks, Study Says 3Health News:Long-Term Use of Antibiotic May Help Those With COPD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 3Health News:Racial Disparities Seen in U.S. Lung Cancer Treatment 2
... The first results of the first European survey of cancer ... 6th congress of the European Federation of Chapters of the ... surveys have looked at the overall management of pain in ... look in detail at Breakthrough Cancer Pain (BTCP) from a ...
... ... Proactive Wellness Centers, PLC -- a leading Anti-Aging Practice, is the featured speaker at ... in Northern Virginia. , ... Sterling, VA (PRWEB) September 11, 2009 -- Most women understand that health factors ...
... ... specialist Flintec has recruited eight new software and electronic developers to ... equipment is Flintec,s fastest growing area of business. Increasing numbers of ... build the precision measuring systems at the heart of their life-saving ...
... , , NEW YORK, Sept. ... and The Mount Sinai Medical Center describe the Community Diabetes ... outreach program which was designed specifically for people from the vulnerable ... Twenty-five patients from The Mount Sinai Medical Center were randomly ...
... , , , ... industry leader, declared his support for H.R. 1891, a House bill ... deduction. Roeser is Senior Vice President of Marketing and Operations for ... -- one of the nation,s largest and most experienced long-term care ...
... , VOORHEES, N.J., Sept. 10 Angioedema is ... organs, and airway, causing discomfort and even death as a result ... the prevention and treatment of angioedema, and new therapies are being ... patient population. , , To address the need ...
Cached Medicine News:Health News:First results from major European patient survey show devastating impact of living with breakthrough cancer pain 2Health News:Dr. Lynese Lawson Speaks to Sterling Women: Strategies to Rejuvenate Your Health and Your Career 2Health News:Dr. Lynese Lawson Speaks to Sterling Women: Strategies to Rejuvenate Your Health and Your Career 3Health News:Flintec Load Cell Design Helps to Create Vital Medical Solutions 2Health News:Flintec Load Cell Design Helps to Create Vital Medical Solutions 3Health News:Flintec Load Cell Design Helps to Create Vital Medical Solutions 4Health News:Dr. Eliscer Guzman, with The Mount Sinai Medical Center, Join Forces to Celebrate the Community Diabetes and Cardiovascular Care Program's Graduation Ceremony on September 16th 2Health News:Industry Leader Praises Health Reform Bill that Provides 50% Tax Deduction for Long-Term Care Premiums 2Health News:New Directions in Angioedema: A Focus on Supportive Care and Treatment Options 2
(Date:5/21/2013)...  The North Shore-LIJ Health System is expanding a ... at North Shore University Hospital in Manhasset, ... at Forest Hills (NY) Hospital. ... new pilot program strengthens patient safety by providing hospitals ... first time in the US that remote video auditing ...
(Date:5/21/2013)... -- Vasomedical, Inc. (OTC BB: VASO) (the "Company"), a diversified medical ... medical devices and in the domestic sale of diagnostic imaging ... , President and CEO of Vasomedical, Inc. will present at ... 30, 2013 in New York City ... presentation is scheduled to begin at 9:30 a.m. EDT. ...
(Date:5/21/2013)... BioElectronics Corp. (PINKSHEETS: BIEL), the maker ... that CEO, Andrew J. Whelan ... Advisory Committee, Orthopedic and Rehabilitation Panel compelling arguments ... counter sales. "It,s been 37 years ... schema," Whelan said.  "While the old classification of ...
Breaking Medicine Technology:North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 2North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 3North Shore-LIJ Extends Use of 3rd Party Remote Video Auditing into ORs 4Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2BioElectronics Presents FDA Reclassification Panel 2BioElectronics Presents FDA Reclassification Panel 3
... The BladderScan BVM 6500 ... noninvasively to determine UEBW ... and bladder volume using ... BVM 6500 was designed ...
... Titan™ Inflatable Penile Prosthesis (IPP) ... to be surgically implanted into ... of erectile dysfunction (also known ... the patient with voluntary control ...
... Alpha I continues to be a proven, ... Alpha I to have mechanical reliability rates ... first-time implants. ioflex material contributes to excellent ... Thats because Bioflex: ,Provides maximum, controlled girth ...
... is an advanced three-part inflatable prosthesis consisting of ... placed in the scrotum and a pair of ... simulates the look and performance of a natural ... technology, the AMS 700 Series now features the ...
Medicine Products: